Blog

Key Takeaways from Our London Roundtable: Human Rights Due Diligence in Pharma

We recently hosted a pharma-focused roundtable in partnership with Norton Rose Fulbright at their London office, bringing together senior risk and compliance professionals from across the life sciences industry. [...]
Blog

Economic Pressure, Perverse Incentives, and the Growing Importance of Third-Party Risk Management

The ongoing conflict in Iran has added fresh volatility to an already fragile global economic outlook in 2026, compounding uncertainty around tariffs, sanctions, and wider geopolitical tensions. [...]
Blog

Top 5 Takeaways from Our UK Anti-Bribery & Corporate Crime Webinar

In our recent webinar on the evolving UK anti-bribery and corporate crime landscape, we explored a reality that many compliance leaders are currently grappling with: SFO enforcement may [...]
Blog

What Should Businesses Consider When Re-Entering a High Risk Jurisdiction?

Following the early January 2026 capture of Venezuelan President Nicolás Maduro, the US and Venezuelan governments have been taking steps to encourage new investment.[...]
eBooks/White Papers

2026 Outlook: Navigating Third-Party Risk in the Pharmaceutical and Life Sciences Sector

2026 Outlook: Navigating Third-Party Risk in the Pharmaceutical and Life Sciences Sector Since the release of our 2025 Outlook, the […]
Case Studies

Case Study: Skydio

Skydio, the largest drone manufacturer in North America, supporting local police departments, utilities, and military partners has successfully migrated from the T-Compliance Third-Party Risk Management (TPMS) platform [...]
See all Resources